IE000O5M6XO1
IE000O5M6XO1
ARK Genomic Revolution UCITS ETF
Loading chart...
Holdings & Portfolio Structure
Holdings as of 10/11/2026Detailed breakdown of ETF components
All Holdings
# | Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | D/E | P/B | P/S | EV/EBITDA | P/FCF | FCF Yield | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tempus AI, Inc. | Healthcare | Health Information Services | 11,42 Mrd. € | 8.55% | - | -8767.61 | 324.58% | 28.70 | 8.94 | -67.90 | - | -0.73% | FY Cur +25.43% (22) Q Cur +22.59% (19) FY Next +23.27% (22) Q Next +11.11% (19) | FY Cur +57.22% (16) Q Cur +29.90% (14) FY Next +96.90% (16) Q Next +93.42% (15) | |
| 2 | Twist Bioscience Corporation | Healthcare | Biotechnology | 9,45 Mrd. € | 8.17% | - | -399.45 | 24.36% | 22.47 | 24.53 | -82.20 | - | -0.61% | FY Cur +21.18% (12) Q Cur +24.77% (11) FY Next +20.16% (11) Q Next +2.34% (8) | FY Cur +54.63% (4) Q Cur +67.26% (3) FY Next +58.32% (4) Q Next +6.33% (3) | |
| 3 | 10x Genomics, Inc. | Healthcare | Medical Devices | 9,38 Mrd. € | 7.46% | - | 1051.91 | 9.54% | 12.73 | 17.03 | -232.90 | 58.49 | 1.71% | FY Cur -3.47% (17) Q Cur -0.79% (16) FY Next +9.72% (17) Q Next +16.00% (16) | FY Cur -70.21% (3) Q Cur +12.28% (2) FY Next +109.08% (3) Q Next +75.00% (2) | |
| 4 | Illumina, Inc. | Healthcare | Diagnostics & Research | 37,49 Mrd. € | 5.22% | 51.90 | 45.46 | 89.04% | 14.80 | 9.35 | 35.77 | 52.66 | 1.90% | FY Cur +6.48% (19) Q Cur +6.34% (17) FY Next +6.46% (19) Q Next +5.84% (16) | FY Cur +10.69% (21) Q Cur +1.31% (19) FY Next +14.20% (21) Q Next +13.15% (18) | |
| 5 | Natera, Inc. | Healthcare | Diagnostics & Research | 51,55 Mrd. € | 5.09% | - | -2028.91 | 13.09% | 31.59 | 21.34 | -247.20 | 555.23 | 0.18% | FY Cur +26.17% (22) Q Cur +19.45% (20) FY Next +20.65% (22) Q Next +5.85% (18) | FY Cur +5.05% (16) Q Cur +58.50% (15) FY Next +86.32% (16) Q Next +60.98% (14) | |
| 6 | CRISPR Therapeutics AG | Healthcare | Biotechnology | 4,61 Mrd. € | 5.00% | - | -15.18 | 44.87% | 2.95 | 385.49 | -6.42 | - | -4.18% | FY Cur +204.90% (17) Q Cur +1760.02% (15) FY Next +283.48% (16) Q Next -1.10% (15) | FY Cur +31.18% (18) Q Cur +10.01% (17) FY Next +21.03% (18) Q Next -10.08% (17) | |
| 7 | Absci Corporation | Healthcare | Biotechnology | 1,56 Mrd. € | 4.53% | - | -15.05 | 1.56% | 7.08 | 1116.98 | -11.19 | - | -2.90% | FY Cur +39.03% (10) Q Cur +70.99% (9) FY Next +310.91% (10) Q Next +73.24% (9) | FY Cur +8.38% (7) Q Cur -0.79% (7) FY Next +16.20% (7) Q Next +0.54% (7) | |
| 8 | CareDx, Inc. | Healthcare | Diagnostics & Research | 2,94 Mrd. € | 4.49% | 30.61 | 49.36 | 4.52% | 7.70 | 7.19 | 230.33 | 29.37 | 3.41% | FY Cur +30.36% (7) Q Cur +21.89% (7) FY Next +6.23% (7) Q Next +1.27% (7) | FY Cur +106.61% (6) Q Cur -8.93% (6) FY Next +7.65% (6) Q Next -9.15% (6) | |
| 9 | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 938,15 Mrd. € | 4.18% | 39.26 | 24.76 | 162.07% | 31.03 | 13.19 | 26.10 | 94.99 | 1.05% | FY Cur +35.78% (28) Q Cur +27.08% (14) FY Next +15.65% (28) Q Next +4.56% (15) | FY Cur +47.76% (27) Q Cur +15.31% (17) FY Next +33.16% (27) Q Next +24.20% (17) | |
| 10 | Personalis, Inc. | Healthcare | Diagnostics & Research | 1,52 Mrd. € | 3.62% | - | -17.02 | 16.16% | 7.24 | 24.52 | -14.73 | - | -3.28% | FY Cur +21.10% (3) Q Cur +47.27% (3) FY Next +30.66% (7) Q Next +18.14% (3) | FY Cur -18.68% (5) Q Cur -5.55% (6) FY Next +12.96% (7) Q Next +6.58% (6) | |
| 11 | Veracyte, Inc. | Healthcare | Diagnostics & Research | 3,25 Mrd. € | 3.49% | 32.31 | 23.25 | 2.89% | 2.62 | 6.47 | 26.96 | 34.23 | 2.92% | FY Cur +14.80% (13) Q Cur +11.59% (12) FY Next +10.94% (13) Q Next +6.89% (12) | FY Cur +7.43% (12) Q Cur -19.49% (12) FY Next +1.74% (12) Q Next +9.03% (12) | |
| 12 | Intellia Therapeutics, Inc. | Healthcare | Biotechnology | 1,63 Mrd. € | 3.20% | - | -5.09 | 10.09% | 2.51 | 30.78 | -3.38 | - | -13.64% | FY Cur -23.33% (17) Q Cur -29.13% (15) FY Next +143.36% (17) Q Next +74.94% (15) | FY Cur +17.43% (17) Q Cur +14.47% (16) FY Next +18.40% (17) Q Next +4.48% (16) | |
| 13 | Beam Therapeutics Inc. | Healthcare | Biotechnology | 2,37 Mrd. € | 3.18% | - | -5.42 | 23.17% | 2.41 | 17.01 | -4.36 | - | -9.11% | FY Cur -65.24% (14) Q Cur +2.70% (12) FY Next +29.19% (12) Q Next +16.18% (12) | FY Cur -449.82% (14) Q Cur -6.32% (13) FY Next -6.46% (12) Q Next -1.49% (13) | |
| 14 | Guardant Health, Inc. | Healthcare | Diagnostics & Research | 20,06 Mrd. € | 3.13% | - | -405.82 | - | - | 19.00 | -53.09 | 844.66 | 0.12% | FY Cur +38.24% (25) Q Cur +32.20% (21) FY Next +35.29% (25) Q Next +5.32% (20) | FY Cur +19.43% (21) Q Cur +19.79% (17) FY Next +71.86% (19) Q Next +11.31% (17) | |
| 15 | Recursion Pharmaceuticals, Inc. | Healthcare | Biotechnology | 2,09 Mrd. € | 3.02% | - | -4.83 | 7.28% | 2.55 | 42.62 | -3.47 | - | -9.39% | FY Cur -48.04% (8) Q Cur +151.98% (7) FY Next +34.96% (8) Q Next +3.28% (7) | FY Cur +35.33% (7) Q Cur +35.97% (6) FY Next +3.16% (7) Q Next +1.77% (6) | |
| 16 | COMPASS Pathways Plc - American | Healthcare | Medical Care Facilities | 1,48 Mrd. € | 2.88% | - | -8.37 | 64.62% | 19.26 | - | -6.52 | 6.65 | 15.04% | FY Cur +0.00% (14) Q Cur +0.00% (14) FY Next - (15) Q Next - (14) | FY Cur +14.87% (4) Q Cur +13.97% (4) FY Next +4.76% (3) Q Next -17.42% (4) | |
| 17 | Schrodinger, Inc. | Healthcare | Health Information Services | 1,82 Mrd. € | 2.66% | - | -20.21 | 32.83% | 6.04 | 7.88 | -11.30 | - | -1.43% | FY Cur -5.14% (7) Q Cur -10.63% (6) FY Next +3.12% (7) Q Next +53.82% (5) | FY Cur +9.47% (1) Q Cur +8.77% (1) FY Next +26.23% (1) Q Next +69.23% (1) | |
| 18 | Nurix Therapeutics, Inc. | Healthcare | Biotechnology | 2,07 Mrd. € | 2.50% | - | -20.98 | 14.44% | 5.76 | 63.09 | -5.43 | - | -7.10% | FY Cur +799.42% (4) Q Cur +5974.51% (3) FY Next -84.01% (4) Q Next -44.66% (3) | FY Cur +210.70% (3) Q Cur +596.47% (3) FY Next -131.55% (3) Q Next -107.21% (3) | |
| 19 | Butterfly Network, Inc. | Healthcare | Medical Devices | 1,96 Mrd. € | 2.20% | - | -145.58 | 10.08% | 11.52 | 19.59 | -43.42 | 2373.37 | 0.04% | FY Cur +24.76% (6) Q Cur +32.16% (6) FY Next +23.86% (6) Q Next +20.73% (5) | FY Cur +22.92% (4) Q Cur +25.00% (3) FY Next +38.74% (3) Q Next +33.33% (3) | |
| 20 | Adaptive Biotechnologies Corpor | Healthcare | Diagnostics & Research | 3,77 Mrd. € | 1.93% | - | -146.80 | 272.46% | 29.50 | 13.72 | -198.71 | 222.78 | 0.45% | FY Cur +5.94% (9) Q Cur -23.77% (8) FY Next +22.42% (9) Q Next +10.62% (8) | FY Cur -39.11% (7) Q Cur -259.27% (7) FY Next +66.74% (7) Q Next +32.89% (7) | |
| 21 | Ionis Pharmaceuticals, Inc. | Healthcare | Biotechnology | 6,72 Mrd. € | 1.80% | - | -40.71 | 497.80% | 17.05 | 8.61 | -12.57 | - | -4.61% | FY Cur -2.59% (23) Q Cur +18.68% (18) FY Next +48.21% (23) Q Next +28.75% (18) | FY Cur -75.03% (10) Q Cur -49.59% (8) FY Next +58.84% (10) Q Next +3.14% (8) | |
| 22 | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 1,79 Mrd. € | 1.77% | - | 56.18 | 68.55% | 8.22 | 4.42 | -60.98 | - | -2.37% | FY Cur +12.70% (9) Q Cur +5.30% (8) FY Next +24.31% (8) Q Next +16.04% (8) | FY Cur -90.61% (7) Q Cur -85.13% (7) FY Next +811.95% (7) Q Next +339.20% (7) | |
| 23 | Arcturus Therapeutics Holdings | Healthcare | Biotechnology | 348,55 Mio. € | 1.75% | - | -3.71 | 13.35% | 2.27 | 13.30 | -1.98 | 20.28 | 4.93% | FY Cur -77.27% (13) Q Cur -53.12% (13) FY Next +64.21% (12) Q Next -29.03% (13) | FY Cur -43.94% (10) Q Cur -38.85% (10) FY Next -7.19% (10) Q Next -36.51% (10) | |
| 24 | Prime Medicine, Inc. | Healthcare | Biotechnology | 645,9 Mio. € | 1.36% | - | -4.49 | 282.54% | 17.73 | 177.68 | -3.46 | - | -10.47% | FY Cur +90.65% (13) Q Cur -10.55% (11) FY Next +19.47% (13) Q Next +489.46% (11) | FY Cur +30.02% (14) Q Cur +26.98% (13) FY Next +6.01% (12) Q Next +7.21% (13) | |
| 25 | Alamar Biosciences, Inc. | Healthcare | Medical Devices | 1,57 Mrd. € | 1.35% | - | -46.58 | 16.43% | 5.60 | 17.46 | -42.67 | - | - | FY Cur +18.08% (5) Q Cur - (5) FY Next +39.75% (5) Q Next +8.92% (5) | FY Cur - (4) Q Cur - (4) FY Next +53.40% (4) Q Next -0.01% (4) |
Results: 33
Weight 8.55%
Market Cap €11.42B
P/E -
Fwd P/E -8767.6
Weight 8.17%
Market Cap €9.45B
P/E -
Fwd P/E -399.4
Weight 7.46%
Market Cap €9.38B
P/E -
Fwd P/E 1051.9
Weight 5.22%
Market Cap €37.49B
P/E 51.9
Fwd P/E 45.5
Weight 5.09%
Market Cap €51.55B
P/E -
Fwd P/E -2028.9
Weight 5%
Market Cap €4.61B
P/E -
Fwd P/E -15.2
Weight 4.53%
Market Cap €1.56B
P/E -
Fwd P/E -15.0
Weight 4.49%
Market Cap €2.94B
P/E 30.6
Fwd P/E 49.4
Weight 4.18%
Market Cap €938.15B
P/E 39.3
Fwd P/E 24.8
Weight 3.62%
Market Cap €1.52B
P/E -
Fwd P/E -17.0
Weight 3.49%
Market Cap €3.25B
P/E 32.3
Fwd P/E 23.2
Weight 3.2%
Market Cap €1.63B
P/E -
Fwd P/E -5.1
Weight 3.18%
Market Cap €2.37B
P/E -
Fwd P/E -5.4
Weight 3.13%
Market Cap €20.06B
P/E -
Fwd P/E -405.8
Weight 3.02%
Market Cap €2.09B
P/E -
Fwd P/E -4.8
Weight 2.88%
Market Cap €1.48B
P/E -
Fwd P/E -8.4
Weight 2.66%
Market Cap €1.82B
P/E -
Fwd P/E -20.2
Weight 2.5%
Market Cap €2.07B
P/E -
Fwd P/E -21.0
Weight 2.2%
Market Cap €1.96B
P/E -
Fwd P/E -145.6
Weight 1.93%
Market Cap €3.77B
P/E -
Fwd P/E -146.8
Weight 1.8%
Market Cap €6.72B
P/E -
Fwd P/E -40.7
Weight 1.77%
Market Cap €1.79B
P/E -
Fwd P/E 56.2
Weight 1.75%
Market Cap €348.55M
P/E -
Fwd P/E -3.7
Weight 1.36%
Market Cap €645.9M
P/E -
Fwd P/E -4.5
Weight 1.35%
Market Cap €1.57B
P/E -
Fwd P/E -46.6
Results 1 - 25 of 33
Per page:
Page 1 / 2